Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease [Hematologic Malignancy]
Conclusion
The results of this study suggest that patients with PV who have any one of the features in question (known HU use, known phlebotomy, or splenomegaly) have significant PV-associated symptoms. Furthermore, it demonstrates that many PV symptoms remain severe independent of the number of features present.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Geyer, Scherber, Kosiorek, Dueck, Kiladjian, Xiao, Slot, Zweegman, Sackmann, Fuentes, Hernandez-Maraver, Dohner, Harrison, Radia, Muxi, Besses, Cervantes, Johansson, Andreasson, Rambaldi, Barbui, Bonatz, Reiter, Boyer, Etienne, Ianotto, Ranta, Roy, Cahn, Tags: Translational Oncology, Quality of Life Hematologic Malignancy Source Type: research
More News: Cancer & Oncology | Hematology | Laboratory Medicine | Myeloproliferative Disorders | Phlebotomy | Study